Production of epitope-specific antibodies by immunization with synthetic epitope peptide formulated with CpG-DNA-liposome complex without carriers

Methods in Molecular Biology

Volumn 1348, Issue , 2015, Pages 127-135

  Kim, Dongbum ^a   Lee, Younghee ^a   Kwon, Hyung Joo ^a  

^a NONE

Author keywords

Antibody production; CpG DNA; CpG DNA liposome complex; Epitope; Peptide

Indexed keywords

ANTIBODY; B LYMPHOCYTE ANTIGEN; CHOLESTEROL HYDROGEN SUCCINATE; CPG DNA LIPOSOME COMPLEX; CPG OLIGODEOXYNUCLEOTIDE; EPITOPE; ETHANOLAMINE DERIVATIVE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; LIPOSOME; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; OLIGODEOXYRIBONUCLEOTIDE; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HYDROPHILICITY; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; ANIMAL; IMMUNIZATION; IMMUNOLOGY; SYNTHESIS;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; EPITOPES, B-LYMPHOCYTE; IMMUNIZATION; LIPOSOMES; MICE; OLIGODEOXYRIBONUCLEOTIDES; PEPTIDES;

EID: 84942902550     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2999-3_13     Document Type: Chapter

References (21)

1. Ben-Yedidia T, Arnon R (1997) Design of peptide and polypeptide vaccines. Curr Opin Bio technol 8:442–448
2. Bijker MS, Melief CJ, Offringa R et al (2007) Design and development of synthetic peptide vaccines: past, present and future. Expert Rev Vaccines 6:591–603
3. Simoes S, Moreira JN, Fonseca C et al (2004) On the formulation of pH-sensitive liposomes with long circulation times. Adv Drug Deliv Rev 56:947–965
4. Chikh G, Schutze-Redelmeier MP (2002) Liposomal delivery of CTL epitopes to dendritic cells. Biosci Rep 22:339–353
5. Felnerova D, Viret JF, Gluck R et al (2004) Liposomes and virosomes as delivery system for antigens, nucleic acids and drugs. Curr Opin Biotechnol 15:518–529
6. Ben-Yedidia T, Marcus H, Reisner Y et al (1999) Intranasal administration of peptide vaccine protects human/mouse radiation chimera from infl uenza infection. Int Immunol 11:1043–1051
7. Li WM, Dragowska WH, Bally MB et al (2003) Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/ neu-derived peptide co-encapsulation in liposomes. Vaccine 21:3319–3329
8. Kreig AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709–760
9. Krieg AM (2006) Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov 5:471–484
10. Lee KW, Jung J, Lee Y et al (2006) Immuno stimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA. Mol Immunol 43:2107–2118
11. Kim D, Kwon S, Rhee JW et al (2011) Production of antibodies with peptide-CpGDNA- liposome complex without carriers. BMC Immunol 12:29
12. Kim D, Kwon HJ, Lee Y (2011) Activation of Toll-like receptor 9 and production of epitope specific antibody by liposomeencapsulated CpG-DNA. BMB Rep 44: 607–612
13. Kwon S, Kim D, Park BK et al (2012) Prevention and therapy of hepatocellular carcinoma by vaccination with TM4SF5 epitope- CpG- liposome complex without carriers. PLoS One 7:e33121
14. Kwon S, Choi KC, Kim YE et al (2014) Monoclonal antibody targeting of the cell surface molecule TM4SF5 inhibits the growth of hepatocellular carcinoma. Cancer Res 74:3844–3856
15. Rhee JW, Kim D, Park BK et al (2012) Immunization with a hemagglutinin-derived synthetic peptide formulated with a CpGDNA- liposome complex induced protection against lethal infl uenza virus infection in mice. PLoS One 7:e48750
16. Parker JM, Hodges PC (1986) New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and x-ray-derived accessible sites. Biochemistry 25:5425–5432
17. Emini EA, Hughes JV, Perlow DS et al (1985) Induction of hepatitis A virus-neutralizing antibody by a virus-specifi c synthetic peptide. J Virol 55:836–839
18. Chou PY, Fasman GD (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 47:45–148
19. Kolaskar AS, Tongaonkar PC (1990) A semiempirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276:172–174
20. Yokoyama WM, Christensen M, Santos GD et al (2006) Production of monoclonal antibodies. In: Coligan JE, Bierer B (eds) Current protocols in immunology. Wiley, New York, Chapter 2, Unit 2 5
21. Kim D, Rhee JW, Kwon S et al (2009) Immunostimulation and anti-DNA antibody production by backbone modifi ed CpGDNA. Biochem Biophys Res Commun 379: 362–367